A clinical formulation indicated for Heart and Blood Pressure. Mechanism of action focuses on sequestering specific clotting enzymes, which provides support in preventing thromboembolic events.
Utilized to manage blood clotting risks by addressing coagulation proteins to alleviate stroke danger and mitigate the recurrence of venous thromboembolism in adults.
Mechanism of Action
Rivaroxaban blocks Factor Xa, a vital protein in the blood clotting cascade. By stopping this factor, the body cannot produce thrombin, the substance needed to form a solid blood clot.
Route of Administration
Oral
Onset Time
2–4 hours
Duration
24 hours
Contraindications
Active major bleeding, Severe kidney disease, Severe liver disease, Pregnancy, Prosthetic heart valves
Information for Xarelto is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
